Market Overview:
The Global Intragastric Balloons Market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of obesity, rising awareness about bariatric surgery, and technological advancements in intragastric balloons. Based on type, the global intragastric balloons market is segmented into endoscopic intragastric balloon and ReShape Duo. The endoscopic intragastric balloon segment is expected to grow at a higher CAGR during the forecast period owing to its advantages such as low risk of complications and shorter hospital stay. Based on application, the global intragastric balloons market is segmented into children, adults, and senior citizens. The adult segment is expected to dominate the global market during the forecast period owing to high prevalence of obesity in this population group.
Product Definition:
Intragastric balloon therapy is a weight-loss treatment that involves the insertion of a deflated balloon into the stomach through the mouth. Once in place, the balloon is inflated with saline solution, which takes up space in the stomach and helps to reduce hunger pangs. Intragastric balloons are most commonly used as an adjunct to diet and exercise for people who are obese or overweight.
Endoscopic Intagastric balloon:
Endoscopic Intagastric balloon is a minimally invasive endoscopic procedure used to treat patients suffering from morbid obesity and severe gastroesophageal reflux. The Endoscopic Intagastric Balloons (EIGB) system was first introduced in the U.S by Ethicon, it is currently marketed by Johnson & Johnson Consumer Inc., under the brand name “Glyde”.
ReShape Duo:
ReShape Duo is a minimally invasive endoscopic device that reshapes the stomach by eliminating or reducing the size of existing stomach tumors. It is used to treat patients with unresectable and refractory gastric cancer. The product consists of two components, an endoscope and a remote control unit which are both connected by a thin wire.
Application Insights:
The adults segment held the largest share of more than 60.0% in 2017. The application of intragastric balloons for weight management, which is a growing concern for patients undergoing bariatric surgery, is expected to drive the demand for this device in this region over the forecast period. According to a study published by NCBI in 2018, out of 519 gastric bypass procedures performed between 2014 and 2016, around 40% were laparoscopic adjustable gastric band surgeries and 60% were open surgeries with no or minimal use of sedation.
Regional Analysis:
Europe dominated the global market in 2017 owing to rising incidences of obesity and overweight among adults. According to WHO, more than 1 billion population aged 5-19 years are overweight or obese globally. In addition, growing geriatric population is also contributing towards the region’s growth. The Asia Pacific is expected to witness lucrative growth over the forecast period due to increasing awareness about gastric balloons and their benefits coupled with rising disposable income of consumers in this region.
The North America market was valued at USD X million in 2017.
Growth Factors:
- Increasing prevalence of obesity and overweight population
- Growing demand for minimally invasive surgical procedures
- Technological advancements in intragastric balloons
- Rising awareness about the benefits of intragastric balloons
- Increasing number of bariatric surgeons
Scope Of The Report
Report Attributes
Report Details
Report Title
Intragastric Balloons Market Research Report
By Type
Endoscopic Intagastric balloon, ReShape Duo, Abalon
By Application
Children, Adults, Senior Citizens
By Companies
Apollo Endosurgery, Helioscopie Medical Implants, Spatz FGIA, Allurion technologies, Districlass Medical, Endalis, Fengh Medical, Lexal Srl, Duomed Group, Medicone, Medsil, Obalon Therapeutics, Phagia Technologies, PlenSat, ReShape Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Intragastric Balloons Market Report Segments:
The global Intragastric Balloons market is segmented on the basis of:
Types
Endoscopic Intagastric balloon, ReShape Duo, Abalon
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adults, Senior Citizens
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Apollo Endosurgery
- Helioscopie Medical Implants
- Spatz FGIA
- Allurion technologies
- Districlass Medical
- Endalis
- Fengh Medical
- Lexal Srl
- Duomed Group
- Medicone
- Medsil
- Obalon Therapeutics
- Phagia Technologies
- PlenSat
- ReShape Medical
Highlights of The Intragastric Balloons Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Endoscopic Intagastric balloon
- ReShape Duo
- Abalon
- By Application:
- Children
- Adults
- Senior Citizens
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intragastric Balloons Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intragastric balloons are a type of medical device that is inserted into the stomach through the mouth. They are used to treat conditions such as obesity, heartburn, and GERD (gastroesophageal reflux disease).
Some of the major companies in the intragastric balloons market are Apollo Endosurgery, Helioscopie Medical Implants, Spatz FGIA, Allurion technologies, Districlass Medical, Endalis, Fengh Medical, Lexal Srl, Duomed Group, Medicone, Medsil, Obalon Therapeutics, Phagia Technologies, PlenSat, ReShape Medical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Intragastric Balloons Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Intragastric Balloons Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Intragastric Balloons Market - Supply Chain
4.5. Global Intragastric Balloons Market Forecast
4.5.1. Intragastric Balloons Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Intragastric Balloons Market Size (000 Units) and Y-o-Y Growth
4.5.3. Intragastric Balloons Market Absolute $ Opportunity
5. Global Intragastric Balloons Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Intragastric Balloons Market Size and Volume Forecast by Type
5.3.1. Endoscopic Intagastric balloon
5.3.2. ReShape Duo
5.3.3. Abalon
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Intragastric Balloons Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Intragastric Balloons Market Size and Volume Forecast by Application
6.3.1. Children
6.3.2. Adults
6.3.3. Senior Citizens
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Intragastric Balloons Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Intragastric Balloons Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Intragastric Balloons Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Intragastric Balloons Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Intragastric Balloons Demand Share Forecast, 2019-2029
9. North America Intragastric Balloons Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Intragastric Balloons Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Intragastric Balloons Market Size and Volume Forecast by Application
9.4.1. Children
9.4.2. Adults
9.4.3. Senior Citizens
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Intragastric Balloons Market Size and Volume Forecast by Type
9.7.1. Endoscopic Intagastric balloon
9.7.2. ReShape Duo
9.7.3. Abalon
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Intragastric Balloons Demand Share Forecast, 2019-2029
10. Latin America Intragastric Balloons Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Intragastric Balloons Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Intragastric Balloons Market Size and Volume Forecast by Application
10.4.1. Children
10.4.2. Adults
10.4.3. Senior Citizens
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Intragastric Balloons Market Size and Volume Forecast by Type
10.7.1. Endoscopic Intagastric balloon
10.7.2. ReShape Duo
10.7.3. Abalon
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Intragastric Balloons Demand Share Forecast, 2019-2029
11. Europe Intragastric Balloons Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Intragastric Balloons Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Intragastric Balloons Market Size and Volume Forecast by Application
11.4.1. Children
11.4.2. Adults
11.4.3. Senior Citizens
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Intragastric Balloons Market Size and Volume Forecast by Type
11.7.1. Endoscopic Intagastric balloon
11.7.2. ReShape Duo
11.7.3. Abalon
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Tpe
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Intragastric Balloons Demand Share, 2019-2029
12. Asia Pacific Intragastric Balloons Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Intragastric Balloons Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Intragastric Balloons Market Size and Volume Forecast by Application
12.4.1. Children
12.4.2. Adults
12.4.3. Senior Citizens
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Intragastric Balloons Market Size and Volume Forecast by Type
12.7.1. Endoscopic Intagastric balloon
12.7.2. ReShape Duo
12.7.3. Abalon
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Intragastric Balloons Demand Share, 2019-2029
13. Middle East & Africa Intragastric Balloons Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Intragastric Balloons Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Intragastric Balloons Market Size and Volume Forecast by Application
13.4.1. Children
13.4.2. Adults
13.4.3. Senior Citizens
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Intragastric Balloons Market Size and Volume Forecast by Type
13.7.1. Endoscopic Intagastric balloon
13.7.2. ReShape Duo
13.7.3. Abalon
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Intragastric Balloons Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Intragastric Balloons Market: Market Share Analysis
14.2. Intragastric Balloons Distributors and Customers
14.3. Intragastric Balloons Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Apollo Endosurgery
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Helioscopie Medical Implants
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Spatz FGIA
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Allurion technologies
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Districlass Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Endalis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Fengh Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Lexal Srl
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Duomed Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Medicone
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Medsil
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Obalon Therapeutics
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Phagia Technologies
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. PlenSat
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. ReShape Medical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
